Application of Hydroxyapatite Obtained by Different Techniques: Metabolism and Microarchitecture Characteristics (Review).

V A Markelov, K V Danilko, V A Solntsev, S V Pyatnitskaya, A R Bilyalov

Abstract readReview

In one paragraph

Review in Sovremennye tekhnologii v meditsine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

V A MarkelovPhD Student, Institute of Biochemistry and Genetics; Ufa Federal Research Center, Russian Academy of Sciences, 71 Oktyabr Avenue, Republic of Bashkortostan, Ufa, 450054, Russia; Junior Researcher, Laboratory of Cell Cultures, Institute of Fundamental Medicine; Bashkir State Medical University, 3 Lenin St., Republic of Bashkortostan, Ufa, 450008, Russia.

K V DanilkoPhD, Associate Professor, Department of Biology, Acting Head of Cell Culture Laboratory, Institute of Fundamental Medicine; Bashkir State Medical University, 3 Lenin St., Republic of Bashkortostan, Ufa, 450008, Russia.

V A SolntsevJunior Researcher, Cell Culture Laboratory, Institute of Fundamental Medicine; Bashkir State Medical University, 3 Lenin St., Republic of Bashkortostan, Ufa, 450008, Russia.

S V PyatnitskayaPhD, Associate Professor, Department of Internal Diseases; Senior Researcher, Cell Culture Laboratory, Institute of Fundamental Medicine; Bashkir State Medical University, 3 Lenin St., Republic of Bashkortostan, Ufa, 450008, Russia.

A R BilyalovPhD, Associate Professor, Department of Traumatology and Orthopedics with a Course of the Institute of Continuing Professional Education; Bashkir State Medical University, 3 Lenin St., Republic of Bashkortostan, Ufa, 450008, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The literature reports on microarchitecture and metabolism characteristics of synthetic hydroxyapatite obtained by different techniques were analyzed. The direct relation between hydroxyapatite production process and its microarchitecture was stated to exist. In turn, hydroxyapatite microarchitecture largely specifies its metabolism characteristics (a number of processes related to calcium and phosphorus metabolism). Therefore, with reference to the metabolism of synthetic hydroxyapatite with various microarchitectures, we analyzed the relationship of the material under study with the immune system cells. Particular emphasis was given to the relationship of hydroxyapatite characteristics with a recipient's immune system due to the material microarchitecture. The review assessed the possible participation of cell mitochondria in synthetic hydroxyapatite metabolism. There were compared the findings of a recipient's immune system

Indexed as

DurapatiteAnimalsBiocompatible MaterialsBone SubstitutesHumansBiocompatible MaterialsBone SubstitutesDurapatitebone graftinghydroxyapatitehydroxyapatite metabolismmicroarchitecture

Identifiers

PMID39896152

DOI10.17691/stm2024.16.6.06

PMCPMC11780588

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.